Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PLAYTECH PLC. We currently have 0 research reports from 0 professional analysts.
|05Apr17 15:41||RNS||Holding(s) in Company|
|17Mar17 17:00||RNS||Holding(s) in Company|
|16Mar17 13:00||RNS||Holding(s) in Company|
|15Mar17 07:00||RNS||Variation in Brickington lock-up arrangement|
|02Mar17 15:51||RNS||Holding(s) in Company|
|01Mar17 15:22||RNS||Director/PDMR Shareholding|
|23Feb17 07:00||RNS||Final Results|
Frequency of research reports
Research reports on
Small Cap Breakfast
19 Apr 17
Global Ports Holding—Intention to float on Standard List. International cruise ports operator. Seeking $250m raise including $75m primary offer. Dorcaster—Schedule One Update. Admission now expected 3 May. RTO of Escape Hunt raising £14m at 135p Verditek— Intention to float on AIM. On Admission, the Company's subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Raising £3.5m. Admission in May. Eddie Stobart Logistics— Schedule 1. Admission expected 25 April but capital raising details TBC. ADES International Holding— Intends to join the Standard List in May raising up to $170m plus a vendor sale. Provider of offshore and onshore oil and gas drilling and production services in the Middle East and Africa. Admission expected in May. Tufton Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
N+1 Singer - Morning Song 20-04-2017
20 Apr 17
Carpetright (CPR LN) Preview – FY pre-close update due on Tuesday | SDL (SDL LN) Disposal of Social Intelligence | Senior (SNR LN) Q1 trading in line | Senior (SNR LN) Q1 trading in line | Servelec Group (SERV LN) Calling the bottom | Trifast (TRI LN) FY17 results ahead of expectations
Strong final results
20 Apr 17
The group has reshaped its business over the past two years, strengthening management and operational infrastructure, increasing capacity and reviewing strategic emphasis. We anticipate a progressive revaluation given the potential growth profile in an addressable and fragmented international market. Our 2017 forecasts remain unchanged following the results which imply EBITDA growth of 26%, and we raise our target price to 6p, implying potential share price upside of 23%.